The efficacy and safety of furmonertinib in patients with advanced EGFR-mutated NSCLC and leptomeningeal metastases. This is an ASCO Meeting Abstract from the 2024 ASCO Annual Meeting I. This abstract ...
Disparities in glioblastoma care: Insights from a nationwide survey. This is an ASCO Meeting Abstract from the 2025 ASCO Annual Meeting I. This abstract does not include a full text component.
First-degree relatives experienced an MS incidence of 211 per 100,000 per year, roughly 100-fold above sporadic MS rates, with median 2-year time to conversion and diagnosis at 37. Evolving ...
Objectives Youth football players are vulnerable to apophyseal injuries, which can have long-term consequences for health and performance. The objective was to assess the incidence, severity and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results